Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00195130 · ClinicalTrials.gov registry record

Prognostic Measures in Ambulatory Care Settings

A clinical trial, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
2,000
Enrollment target

NCT00195130: Completed study, sponsored by Weill Medical College of Cornell University.

NCT00195130 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 2,000 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00195130 has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
2,000 participants
Enrollment target

Study Summary

The primary objective of this prospective study is to develop a new method of classifying the prognosis of ambulatory patients according to their risk of long term mortality, institutionalization, morbidity (including the deterioration of pre-existing conditions or development of new problems) and functional deterioration.

Interventions

  • BEHAVIORAL There are no interventions in this study

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 1998-01
Est. Completion 1999-01

What the finished NCT00195130 record still lists

NCT00195130 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 1 intervention - of which There are no interventions in this study is the first listed.

NCT00195130 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00195130 about?

NCT00195130 is a clinical study titled "Prognostic Measures in Ambulatory Care Settings". The primary objective of this prospective study is to develop a new method of classifying the prognosis of ambulatory patients according to their risk of long term mortality, institutionalization, morbidity (including the deterioration of pre-existing conditions or development of new problems) and f...

What is the current status of trial NCT00195130?

This trial is currently completed. The enrollment target is 2,000 participants. The study started on 1998-01. Estimated completion is 1999-01.

What interventions are being tested in trial NCT00195130?

The interventions under investigation include: There are no interventions in this study (BEHAVIORAL).

Who is sponsoring clinical trial NCT00195130?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001465 · 2,000 participants

    Study of the Disease Process of Lymphangioleiomyomatosis

  • NCT00001595 · 2,000 participants

    An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

  • NCT00138931 · 2,000 participants

    Genetics of Cardiovascular and Neuromuscular Disease

  • NCT00288119 · 2,000 participants

    Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00195130, the US trial registry maintained by the National Library of Medicine. NCT00195130 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.